Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2831-2840 of 10948

Edit search filters
  1. A Study To Evaluate ARV-806 In Adults With Advanced Cancer That Has The KRAS G12D Mutation

    Scottsdale/Phoenix, AZ

  2. A First-in-Human Study Of MEN2312 In Adults With Advanced Breast Cancer

    Rochester, MN

  3. Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa

    Scottsdale/Phoenix, AZ

  4. Acoustic Resonance Therapy (ART) to Cognitive Behavioral Therapy for Insomnia (CBT-I) for Treating Patients with Moderate to Severe Chronic Insomnia

    Rochester, MN

  5. Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)

    Jacksonville, FL

  6. Inspiratory Muscle Training In HFpEF

    Rochester, MN

  7. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes

    Rochester, MN

  8. Clinical Study Of Ivonescimab For First-line Treatment Of Metastatic NSCLC Patients

    Jacksonville, FL, Rochester, MN

  9. A Study Investigating Oral Ozanimod (RPC1063) In Pediatric Participants With Moderate To Severe Active Ulcerative Colitis

    Rochester, MN

  10. Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

.

Mayo Clinic Footer